| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |